TLDR:
- Toronto-based venture capital firm, Cross-Border Impact Ventures (CBIV), has closed its first fund at over $90 million.
- The Women’s and Children’s Health Technology Fund focuses on investing in technology companies that address the health needs of women, children, and adolescents, or make health systems more resilient.
Cross-Border Impact Ventures (CBIV) has announced the closing of its first fund, the Women’s and Children’s Health Technology Fund, at over $90 million. The Toronto-based women-owned venture capital firm primarily invests in technology companies that focus on improving the health of women, children, and adolescents, as well as making health systems more resilient. This fund aims to support innovation in the healthcare sector and address the specific needs of these demographics.
CBIV’s investment strategy is guided by the belief that targeted investments in technology can lead to significant advancements in women’s and children’s health. By investing in companies that develop innovative solutions, CBIV contributes to advancements in treating specific health conditions and improving overall healthcare systems.
The fund’s closure is a result of successful fundraising efforts, indicating a strong interest in supporting health technology companies focused on women’s and children’s health. The funding will enable CBIV to continue making strategic investments in innovative companies and play a vital role in shaping the future of healthcare.
